Voyager Therapeutics, Inc. · NASDAQ:VYGR
Armistice Capital, LLC reported a 9.88% stake in Voyager Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 9.88% stake in Voyager Therapeutics, Inc., 5,396,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.88%
- Shares
- 5,396,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.88% | 5,396,000 |
| Steven Boyd | 9.88% | 5,396,000 |
Source
Related
- Voyager Therapeutics, Inc.
- Armistice Capital, LLC
- Voyager Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 18, 2026
- Schedule 13G/A · Armistice Capital, LLC · Nov 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 31, 2026
- Schedule 13G/A · EcoR1 Capital, LLC · May 15, 2026
- Form 4 · Sandrock Alfred · Apr 3, 2026
- Form 4 · Shiferman Gregory L. · Apr 3, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026